Flagship explainer
What drives GOLDENWELL BIOTECH, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$296471 | FY2025 |
| |
| Income before tax | −$296471 | FY2025 |
|
| Operating income | −$113326 | FY2025 |
|
| $55 | FY2025 |
| |
| Ending assets | $36120 | FY2025 |
|
| Beginning assets | $224192 | FY2024 |
|
| −$85778 | FY2025 |
| |
| $53280 | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001477932-25-003784
- SEC filingFiling detailsAccession 0001477932-26-004130